UK clears Pfizer-BioNTech Covid vaccine ahead of US & EU, to be available from next week

Last month, Pfizer and BioNTech SE had said that the shot, relying on novel technology called messenger RNA, was 95% effective in a final analysis of clinical-trial data.

Pfizer world headquarters in New York | Commons

London: The U.K. became the first western country to approve a Covid-19 vaccine with its regulator clearing Pfizer Inc. and BioNTech SE’s shot ahead of decisions in the U.S. and European Union.

The emergency authorization clears the way for the deployment of a vaccine that’s expected to play a significant role in the global effort to halt the coronavirus. Pfizer and its German partner said in November that the shot, relying on novel technology called messenger RNA, was 95% effective in a final analysis of clinical-trial data.

The vaccine will be available in Britain from next week, according to a statement from the U.K. government.

The U.K. had signaled it would move swiftly in approving a vaccine as part of an operation to protect its population, and doctors across the country were put on standby for a possible rollout. For the government, it’s an opportunity to make up for missteps during the pandemic as Britain’s death toll nears 60,000.- Bloomberg